Entrectinib: a potent new TRK, ROS1, and ALK inhibitor

C. Rolfo, R. Ruiz, E. Giovannetti, I. Gil-Bazo, A. Russo, F. Passiglia, M. Giallombardo, M. Peeters, L. Raez

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)1493-1500
JournalExpert Opinion on Investigational Drugs
Volume24
Issue number11
DOIs
Publication statusPublished - 2015

Cite this

Rolfo, C., Ruiz, R., Giovannetti, E., Gil-Bazo, I., Russo, A., Passiglia, F., ... Raez, L. (2015). Entrectinib: a potent new TRK, ROS1, and ALK inhibitor. Expert Opinion on Investigational Drugs, 24(11), 1493-1500. https://doi.org/10.1517/13543784.2015.1096344